» Articles » PMID: 35268007

Impact of Lifestyle Modifications on Alterations in Lipid and Glycemic Profiles and Uric Acid Values in a Pediatric Population

Overview
Journal Nutrients
Date 2022 Mar 10
PMID 35268007
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiometabolic risk factors are frequent in children and adolescents with excess weight. The aim of this study was to evaluate the effects of lifestyle modifications on alterations in lipid and glycemic profiles and uric acid values in a pediatric population at increased cardiovascular risk. The study involved 276 subjects with a mean age of 10.6 (2.3) years. Body mass index (BMI) z-score and biochemical parameters (serum low-density lipoprotein (LDL) cholesterol, triglycerides and uric acid and homeostasis model assessment to quantify insulin resistance (HOMA index)) were assessed at baseline and at the end of a median follow-up of 14.7 (12.4, 19.3) months. Throughout follow-up, all children received a non-pharmacological treatment based on increased physical activity, reduced sedentary activity and administration of a personalized, healthy and balanced diet. All children attended periodic quarterly control visits during follow-up. Multivariable statistical analyses showed that each BMI z-score point reduction at follow-up was associated with an 8.9 (95% CI −14.2; −3.6) mg/dL decrease in LDL cholesterol (p = 0.001), 20.4 (95% CI −30.0; −10.7) mg/dL in triglycerides (p < 0.001), 1.6 (95% CI −2.2; −1.0) in HOMA index (p < 0.001), and 0.42 (95% CI −0.66; −0.18) mg/dL in uric acid (p = 0.001) values. At each reduction of the BMI z-score by one point, the odds of presenting with insulin resistance and hyperuricemia at follow-up significantly decreased (OR 0.23, 95% CI 0.10−0.50, and OR 0.32, 95% CI 0.10−0.95, p < 0.001 and p < 0.05, respectively). Improvement of dietary habits and lifestyles may improve lipid and glycemic profiles and serum uric acid values in a pediatric population.

Citing Articles

Is Reducing the Obesity Epidemic in Children and Adolescents Really a Mission Impossible?.

Genovesi S, Orlando A, Giussani M Nutrients. 2025; 17(3).

PMID: 39940448 PMC: 11820186. DOI: 10.3390/nu17030592.


The associations of insulin resistance, obesity, and lifestyle with the risk of developing hyperuricaemia in adolescents.

Cheng L, Zhou J, Zhao Y, Wang N, Jin M, Mao W BMC Endocr Disord. 2024; 24(1):220.

PMID: 39420321 PMC: 11488257. DOI: 10.1186/s12902-024-01757-4.


Association between lifestyle modifications and improvement of early cardiac damage in children and adolescents with excess weight and/or high blood pressure.

Genovesi S, Tassistro E, Giussani M, Antolini L, Lieti G, Orlando A Pediatr Nephrol. 2023; 38(12):4069-4082.

PMID: 37349569 PMC: 10584714. DOI: 10.1007/s00467-023-06034-5.


Role of Insulin Resistance as a Mediator of the Relationship between Body Weight, Waist Circumference, and Systolic Blood Pressure in a Pediatric Population.

Genovesi S, Montelisciani L, Giussani M, Lieti G, Patti I, Orlando A Metabolites. 2023; 13(3).

PMID: 36984767 PMC: 10056524. DOI: 10.3390/metabo13030327.


The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review.

Calcaterra V, Verduci E, Vandoni M, Rossi V, Fiore G, Massini G Nutrients. 2022; 14(21).

PMID: 36364954 PMC: 9657567. DOI: 10.3390/nu14214692.


References
1.
Kelsey M, Zeitler P . Insulin Resistance of Puberty. Curr Diab Rep. 2016; 16(7):64. DOI: 10.1007/s11892-016-0751-5. View

2.
Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O . Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018; 17(1):218. PMC: 6138918. DOI: 10.1186/s12944-018-0856-8. View

3.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M . 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018; 27(6):314-340. DOI: 10.1080/08037051.2018.1527177. View

4.
Shaw K, Gennat H, ORourke P, Del Mar C . Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006; (4):CD003817. PMC: 9017288. DOI: 10.1002/14651858.CD003817.pub3. View

5.
Mach F, Baigent C, Catapano A, Koskinas K, Casula M, Badimon L . 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019; 41(1):111-188. DOI: 10.1093/eurheartj/ehz455. View